Objective-Insulin is a key regulator of metabolism, but it also confers protective effects on the cardiovascular system.
I
nsulin is an essential hormone of metabolic homeostasis. Recent clinical findings show that intensive insulin therapy has vasoprotective effects under inflammatory conditions 1, 2 and reduces major cardiovascular events in diabetics. 3 These effects of insulin seem to be independent of its metabolic effects on endothelial cells.
Vascular endothelial cells forming the inner lining of all vessels play an important role in the regulation of vascular homeostasis. They provide a semiselective barrier for water, solutes, macromolecules, and blood-borne components and are also involved in regulating the trafficking of blood cells across the vessel wall. This function can be altered by a variety of diverse circulating vasoactive inflammatory mediators and hormones such as insulin. It has recently been demonstrated that endothelial cells of macrovascular origin express insulin receptors. 4 Binding of insulin to the receptors induces nitric oxide production via phosphatidylinositol 3-kinase (PI3K)-mediated activation of endothelial nitric oxide synthase (eNOS) 5 and causes relaxation of the smooth muscles. Recently, it has been shown that insulin reduces mesenteric venular albumin leakage on systemic insulin administration in rats. 6 However, the underlying signaling mechanism of this effect is largely unknown.
The integrity of the endothelial barrier is highly dependent on the endothelial actomyosin-based contractile machinery [7] [8] [9] and actin cytoskeleton-mediated adherens junctions consisting of VE-cadherin, which, together with other actin binding proteins, seals the adjoining cells and thereby limits the passage of macromolecules across the microvasculature. 10, 11 The activation of endothelial contractile machinery is precisely regulated by phosphorylation state of the regulatory myosin light chains (MLC). 7 MLC phosphorylation increases actin-myosin interaction, cell contraction and barrier failure, whereas reduction in MLC phosphorylation causes stabilization of endothelial barrier. 9, 12 The members of the Rho family of GTPases are key regulators of endothelial barrier function, controlling the endothelial contractile machinery, assembly of actin cytoskeleton, and cell adhesion structures. 11, 13, 14 It is well established that the Rho GTPase Rac1 is required for the stability of endothelial adherens junctions and barrier function. 13, 15 Similarly, activation of Rac1 strengthens VE-cadherin-based cell adhesions and reduces the macromolecule permeability of endothelial monolayers. 16 Rac1 activity is regulated by guanine nucleotide exchange factors, which control the transition of the GDP-bound inactive form to the GTP-bound active form. The activation of Rac1 can be inhibited by the specific pharmacological inhibitor NSC23766, which specifically inhibits Rac1 guanine nucleotide exchange factors Tiam1 and TrioN. 17 The aim of the present study was to analyze whether insulin can enhance the barrier function of coronary microvascular endothelial cells. Special emphasis was laid on the molecular mechanism by which insulin may accomplish this barrier protection.
Materials and Methods
The sources of reagents are listed in the supplemental Materials and Methods section, available online at http://atvb.ahajournals.org.
Isolation and culture of rat coronary microvascular endothelial cells was performed as described previously. 18 Immunoprecipitation was performed by labeling protein-Gcoated magnetic beads with anti-insulin-receptor ␤-subunit antibody followed by Western blotting. Densitometric analyses of Western blots were performed using the Quantity One image analyzer software (Bio-Rad). The procedure is described in detail in the online data supplement.
Endothelial monolayer permeability was measured by the flux of trypan blue-labeled albumin across endothelial monolayers grown on polycarbonate filters and myocardial water content of salineperfused rat heart as an index of coronary leakage, as described previously. 19 
Immunofluorescence Microscopy
The endothelial monolayers cultured on glass coverslips were examined as described previously 19 using a Zeiss LSM-510M inverted microscope.
Data are given as meansϮSD of 3 to 5 experiments using independent cell preparations. The comparison of means between groups was performed by 1-way analysis of variance (ANOVA) followed by a Student-Newman-Keuls post hoc test. Changes in parameters within the same group were assessed by multiple ANOVA analyses. Probability (P) values of less than 0.05 were considered significant.
Results

Effect of Insulin on Insulin Receptors and Endothelial Monolayer Permeability
The presence of insulin receptors in rat coronary microvascular endothelial cells was confirmed by immunoprecipitation with an antibody targeting the ␤-subunit of the insulin receptor ( Figure 1A) . Insulin induced an increase in tyrosine phosphorylation of the ␤-subunit, as shown by reprobe of the Western blot membrane with an antiphosphotyrosine antibody.
The unstimulated endothelial monolayers showed a constant albumin permeability of 4.9Ϯ0.2ϫ10 Ϫ6 cm/s. The addition of insulin caused a prompt reduction in permeability. It dropped within 10 minutes and remained at that lower level for the rest of the period of observations. This reduction was concentration dependent ( Figure 1B  and 1C) ; it was significant as early as 0.001 IU/mL (equivalent to Ϸ5 nmol/L), half-maximal at 0.01 IU/mL, and at its maximum at 1 IU/mL. Therefore, this concentration was used for all further experiments.
To analyze whether insulin can also protect endothelial cells against agonist-induced hyperpermeability, cells were challenged by tumor necrosis factor-␣ (TNF␣). Exposure of endothelial cells to TNF␣ (100 ng/mL) for 30 minutes led to a marked increase in macromolecule permeability, which was reversed by 1 IU/mL insulin ( Figure 1D ).
In the next step, the involvement of insulin receptors in the barrier protective effects of insulin was analyzed. Insulin receptors are receptor-tyrosine-kinases; therefore, genistein, a pan-tyrosine-kinase inhibitor, or HNMPA-(AM) 3, a highly specific insulin-receptor-kinase inhibitor, 20 was applied to block insulin receptors. Preincubation of the cells for 30 minutes with genistein (10 mol/L) significantly attenuated the insulin effect on macromolecule permeability ( Figure  2A ), whereas HNMPA-(AM) 3 (10 mol/L) completely abolished it ( Figure 2B ).
Effect of Insulin on the PI3K/Akt Pathway and Macromolecule Permeability
Insulin mediates most of its effects in endothelial cells via activation of the PI3K/Akt pathway. 5, 21 In line with previous reports, insulin induced a prompt increase in Akt phosphorylation in coronary microvascular endothelial cells in a concentration-dependent manner ( Figure 3A) . Akt phosphorylation reached its maximum within 1 minute and was sustained over the whole period of observation ( Figure 3B ). Maneuvers that inhibit insulin-induced receptor-kinase activation, such as genistein and HNMPA-(AM) 3 , reduced or abolished Akt phosphorylation, respectively ( Figure 3C ) . Likewise, wortmannin (1 mol/L), a PI3K inhibitor, completely abolished insulin-induced Akt phosphorylation. In line with this, wortmannin also completely abrogated the insulin-mediated reduction in macromolecule permeability ( Figure 3D ). Similar results were obtained with LY294002 (data not shown).
Role of Insulin-Induced NO Production in Insulin-Mediated Barrier Stabilization
In line with previous reports, 5 insulin induced NO production in a concentration-dependent manner in coronary microvascular endothelial cells ( Figure 4A ); its effect was at its maximum at 0.1 IU/mL and was completely abolished by preincubation with the competitive eNOS inhibitor N G -nitro-L-arginine methyl ester (L-NAME) (100 mol/L) for 30 minutes. Preincubation of endothelial monolayers with L-NAME, or with N G -nitro-L-Arginine (L-NNA) (100 mol/L) for 30 minutes attenuated but did not abolish the insulin effect on permeability ( Figure 4B ). Because NO mediates many of its actions via activation of soluble guanylate cyclase (sGC) and generation of cGMP, endothelial monolayers were preincubated with 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one (ODQ) (100 mol/L) or 8-bromo-4H-2,5-dioxa-3,9b-diazacyclopenta[a]naphthalen-1-one (NS2028) (100 mol/L), 2 specific sGC inhibitors, for 30 minutes. ODQ and NS2028 attenuated the insulin effect on macromolecule permeability to a similar extent as the eNOS inhibitors ( Figure 4C ).
Effect of Insulin on Contractile Machinery and VE-Cadherin-Mediated Adherens Junctions
The endothelial barrier is regulated by 2 principal mechanisms: the actomyosin-based endothelial contractile machinery and VE-cadherin-dependent adherens junctions. Here, the effect of insulin on both elements was tested. Exposure of endothelial cells to insulin caused a reduction in MLC phosphorylation, which was maximum as early as 0.1 IU/mL ( Figure 5A ). The effect on MLC dephosphorylation was rather delayed and was significant after 10 minutes ( Figure 5B ).
Under control conditions, VE-cadherin was located at the borders of adjacent cells ( Figure 5C and 5D). However, VE-cadherin staining is already enhanced at that site 5 minutes after the addition of insulin (1 IU/mL), indicating that the strengthening effect of insulin on cell-cell adhesion structures precedes inactivation of the contractile machinery. In line with the data on macromolecule permeability, translocation of VE-cadherin to cell-cell junctions was abolished by preincubation with insulin-receptor-kinase inhibitor HNMPA-(AM) 3 (10 mol/L) and the PI3K inhibitor wortmannin (1 mol/L) for 30 minutes. Likewise, insulin-induced translocation of VE-cadherin is only partially inhibited by the NOS inhibitor L-NAME.
Effect of Insulin on Rac1 Activation and Reorganization of Actin Cytoskeleton and Barrier Stabilization
Insulin (1 IU/mL) induced a 3-fold increase in Rac1 activation after 10 minutes ( Figure 6A ). This insulin effect was abolished by insulin-receptor-kinase inhibitor HNMPA-(AM) 3 (10 mol/L) and the PI3K inhibitor wortmannin (1 mol/L), whereas the inhibitors of NOS and sGC, L-NAME (100 mol/L) and ODQ (100 mol/L), respectively, led only to partial inhibition of insulininduced Rac1 activation. This corresponds to a partial inhibitory effect of L-NAME and ODQ on insulinmediated barrier stabilization.
It is well established that Rac1 strengthens adherens junctions via enhancement of the peripheral actin cytoskeleton, accompanied by reduction of F-actin stress fibers. Therefore, the effect of insulin on actin rearrangement was analyzed in early-confluent coronary microvascular endothelial monolayers. Under these conditions, the cells characteristically do not develop a prominent band of peripheral actin but still exhibit F-actin stress fibers running across the cell. Thus, the maneuver inducing actin rearrangement can be easily . Shown is a representative Western blot. Cells were exposed to insulin (1 IU/mL) or vehicle (C) for 10 minutes, and insulin receptor ␤-subunit was immunoprecipitated (IP) and immunoblotted using an antibody targeting the ␤-subunit of the insulin receptor or anti-phosphotyrosine antibody, respectively. B, Effect of insulin on macromolecule permeability. Endothelial monolayers were exposed to different concentrations of insulin or vehicle (control) as indicated. C, Concentrationdependent response of permeability after 10 minutes of exposure to insulin or vehicle (control) as in B. D, Effect of insulin on TNF␣-induced hyperpermeability on macromolecule permeability. Endothelial monolayers were exposed to insulin (1.0 IU/mL), TNF␣ (100 ng/mL), or insulin plus TNF␣ or vehicle (C). Data are meanϮSD of 3 experiments with independent cell preparations. *PϽ0.05 versus control; #PϽ0.05 versus TNF␣.
detected. As shown in Figure 6B , insulin induced formation of peripheral actin band and reduction in stress fibers after 5 minutes of exposure. Preincubation of the monolayers with the insulin-receptor-kinase inhibitor HNMPA-(AM) 3 (10 mol/L), the Rac1 inhibitor NSC23766 (100 mol/L), 17 and the PI3K inhibitor wortmannin (1 mol/L) for 30 minutes abolished peripheral actin band formation, whereas the NOS inhibitor L-NAME only weakly antagonized insulininduced actin reorganization. The role of Rac1 activation in insulin-mediated barrier stabilization was proven by using the Rac1 inhibitor NSC23766. Preincubation of endothelial cells with NSC23766 abolished the insulin effect on endothelial barrier ( Figure 6C) .
A final series of experiments was performed in a wellestablished isolated perfused rat heart model 19 to verify the barrier protective effects of insulin in an intact coronary system. Myocardial water content was determined as an index for capillary leakage. Under control conditions, the myocardial water content of the normoxic perfused rat hearts was 455 mL/100 g dry weight after 90 minutes ( Figure 6D) . Exposure of the hearts to ischemia for 60 minutes followed by 30 minutes of reperfusion caused an increase in myocardial water content to 554 mL/100 g dry weight. In contrast, addition of 0.1 IU/mL insulin, a concentration only one-tenth that applied in the cell culture model, during the first 10 minutes of reperfusion abolished the reperfusion-induced increase in myocardial water content. In one set of experiments, 50 mol/L NSC23766 was added 20 minutes before the onset and during the first 10 minutes of reperfusion. This maneuver abrogated the protective effect of insulin on reperfusion-induced increase in water content.
Discussion
It is well established that intensive insulin therapy reduces vascular complications of the coronary system and other vascular provinces because of its antiatherosclerotic and antiinflammatory effects. [1] [2] [3] Hyperpermeability of macroand microvasculature is the hallmark of these disease states. In the present study, we show for the first time that insulin stabilizes the coronary microvascular endothelial barrier function in an in vitro model of coronary microvascular endothelial cells as well as in the intact coronary vascular system of isolated-perfused rat heart. Insulin not only reduced the basal permeability of endothelial monolayers but also abolished hyperpermeability induced by the inflammatory mediator TNF␣.
Immunoprecipitation experiments revealed the presence of insulin receptors and phosphorylation of the ␤-subunit of the receptor on exposure to insulin. Inhibition of the insulin receptor-tyrosine-kinase abrogated the barrierenhancing effect of insulin, demonstrating a receptormediated effect. In line with the findings of the present study, Sasaki et al 6 have shown that insulin could reduce mesentery venular leakage in rats. However, the molecular mechanism of this insulin effect on endothelial barrier has not been clear until now.
In line with previous reports, 5 we show activation of the PI3K/Akt pathway in coronary microvascular endothelial cells, as demonstrated by Akt phosphorylation. The Akt phosphorylation is rapid and is sustained over longer periods Figure 4 . Role of NO pathway in insulin-mediated reduction of macromolecule permeability. A, Effect of insulin on NO production in endothelial cells. Cells were loaded with DAF2-FM and treated with different concentrations of insulin or L-NAME (100 mol/L) plus insulin (1.0 IU/mL) for 10 minutes, and then DAF-2 triazole production, which is directly related to NO levels, was measured with a fluorescence plate reader. B, Effect of NOS inhibitors L-NAME or L-NNA on insulin-mediated reduction in macromolecule permeability. Endothelial monolayers were exposed to insulin (1 IU/mL), L-NAME (100 mol/L), L-NNA (100 mol/L), insulin plus L-NAME, insulin plus L-NNA, or vehicle of time, similar to its effect on barrier function. Moreover, we demonstrate that this Akt phosphorylation is via receptormediated activation of PI3K. Accordingly, inhibition of PI3K abolished insulin-mediated reduction in permeability, further supporting the notion that insulin strengthens the endothelial barrier via receptor-mediated activation of PI3K/Akt pathway.
Furthermore, we show that insulin induces NO production in endothelial cells under study and inhibition of eNOS with specific inhibitors not only blocked insulin-induced NO production but also attenuated the insulin-mediated barrier stabilization. Accordingly, inhibition of cGMP/protein kinase G (PKG) pathway by specific sGC inhibitors attenuated insulin-mediated barrier protection to a similar extent as eNOS inhibitors, confirming that this is a cGMP/PKG effect. The role of NO in the control of the endothelial barrier is controversial. 22 The NO effect may differ depending on the stimulus, experimental conditions, vascular bed, time window, and local concentration of NO. A number of studies in isolated perfused microvessels, 23 as well as in eNOS knockout mice, 24, 25 show that hyperpermeability induced by growth factors or inflammatory mediators could be attenuated with eNOS inhibitors, supporting the concept that NO triggers this increase in permeability. We have previously demonstrated that vascular endothelial growth factor has a biphasic effect on endothelial permeability. 26 The initial transient barrier protective effect is NO dependent, and inhibition of eNOS abolishes this initial reduction in permeability, suggesting that the NO effect is context dependent and can be influenced by another repertoire of signaling, activated simultaneously by growth factors or inflammatory mediators. Similarly, several other studies have elegantly demonstrated that NO donors and cGMP analogs can antagonize agonist-induced hyperpermeability. 27, 28 Likewise, it has been shown that even basal NO is required for the maintenance of vascular integrity. 29 In line with this, Predescu et al, using eNOS knockout mice, have demonstrated that basal activity of eNOS is indeed required for endothelial adherens junction maintenance independent of vascular bed. 30 Accordingly, the present study demonstrates that insulin, in part, mediates its barrier protective effect via the NO/cGMP pathway. Insulin reduced the state of contractile activation and strengthened adherens junctions in coronary endothelial cells, which explains the mechanistic aspects of this barrier stabilization. Insulin stimulates NO production and reduces MLC phosphorylation, the latter of which is rather delayed and was observed after 10 minutes. The maximum effect on both parameters was obtained at 0.1 IU/mL, a concentration one-tenth that observed for the maximal effect on permeability. Presently, the detailed mechanism of insulin-induced contractile inactivation is still elusive. It has previously been shown that in isolated vessels, a maneuver activating cGMP/ PKG signaling led to dephosphorylation of MLC via activation of MLC phosphatase. 31 Therefore, our data suggest that insulin reduces MLC phosphorlyation via NO/cGMPmediated pathway.
Insulin-induced stabilization of adherens junctions is mediated via translocation of VE-cadherin, a major component of endothelial adherens junctions, to cell-cell junctions. This translocation was abrogated by inhibition of insulin receptortyrosine-kinase, PI3K and weakly attenuated by inhibition of NOS, suggesting that insulin mediates its effect on endothelial adherens junctions via both the PI3K/Akt and the NO pathway.
Rac1, a member of Rho family of GTPases, is known to regulate assembly of peripheral actin and stimulates the formation of adherens junctions. 14, 15, 32 The results of the Representative immunofluorescence images of endothelial monolayers exposed to insulin (1 IU/mL), insulin plus HNMPA-(AM) 3 (HNMP; 10 mol/L), insulin plus wortmannin (Wort; 1 mol/L), insulin plus L-NAME (100 mol/L), insulin plus NSC23766 (NSC; 100 mol/L, Rac1 inhibitor), or vehicle (control). Arrows denote the cell periphery and arrowheads F-actin stress fibers. Scale barϭ20 m; shown are representative images of 3 experiments with independent cell preparations. C, Effect of the Rac1 inhibitor NSC23766 on insulin-mediated reduction of macromolecule permeability. Endothelial cells were exposed to insulin (1 IU/mL), NSC23766 (NSC; 100 mol/L), insulin plus NSC, or vehicle (control) as indicated. Data are meanϮSD of 3 experiments with independent cell preparations. *PϽ0.05 versus control; #PϽ0.05 versus insulin alone). D, Effect of insulin on myocardial water content after ischemia-reperfusion of saline-perfused rat hearts. Hearts were exposed for 60 minutes to ischemia followed by 30 minutes of reperfusion (Rep) or 90 minutes of normoxia (Nor). Insulin (Ins; 0.1 IU/mL) was added at the onset of reperfusion during the first 10 minutes. In one set of experiments, NSC23766 (NSC; 50 mol/L) was added 20 minutes before the onset and in the first 10 minutes of reperfusion. Data are meanϮSD of 5 separate experiments with independent organ preparations. *PϽ0.05 versus Nor; #PϽ0.05 versus Rep. E, Insulin stabilizes microvascular endothelial barrier function: proposed signaling pathways. present study clearly show that insulin activates Rac1 via PI3K/Akt and also in part via the NO/cGMP pathway. This could be mediated via activation of the Rac1-specific guanine nucleotide exchange factors Tiam1 and TrioN, because a specific inhibitor of these guanine nucleotide exchange factors, NSC23766, 17 abolished the insulin effect. Inhibition of PI3K abolished Rac1 activation and reorganization of the peripheral actin cytoskeleton, whereas inhibition of either NOS or sGC led only to partial inhibition of Rac1 and a weak antagonistic effect on peripheral actin. In line with our findings, 2 reports on fibroblasts show that activation of either PI3K/Akt 33 or NO/cGMP 34 can induce Rac1 activation.
Inhibition of Rac1 with a specific inhibitor, NSC23766, 17 abolished the insulin-mediated barrier stabilization effect. Remarkably, the effect of inhibition of Rac1 was much more effective than inhibition of NOS or sGC, indicating that Rac1 is a central signaling element of the insulin-mediated barrier stabilization beyond NO/cGMP pathway. Furthermore, the inability of eNOS and sGC inhibitors to block the initial effect of insulin on permeability and the delayed effect of insulin on MLC phosphorylation suggest that NO signaling does not contribute to the acute but rather to the sustained effect of insulin.
The barrier protective effect of insulin is further supported by our data obtained in an isolated, saline-perfused rat heart model. 19 In this model, insulin caused a strong reduction of the reperfusion-induced increase in myocardial water content if applied for only a short period of time during the early phase of reperfusion. These data indicate that insulin is also a potent stabilizer of the vascular permeability barrier in the intact coronary system and that its application during reperfusion can protect the heart against an imminent edema. This antiedematous effect of insulin was lost if the heart was perfused with insulin in the presence of the Rac1 inhibitor NSC23766, clearly demonstrating that insulin-mediated barrier protection is via Rac1.
Hyperglycemia is a major contributor to endothelial barrier failure 35, 36 and an early feature of diabetic microangiopathy. 36 Substitution of insulin has been shown to be vasoprotective in diabetic rats. 37 Several mechanisms for hyperglycemiainduced vascular leakage have been proposed, including damage to endothelial glycocalyx. 38 Although an acute effect of insulin on glycocalyx has not been analyzed until today, recently it has been shown that long-term insulin administration could protect P-glycoproteins in experimental diabetic rats. 37 In summary, the data of the present study support the concept that insulin stabilizes barrier under basal conditions and protects against imminent failure induced by inflammatory mediators or ischemia-reperfusion injury via inhibition of the contractile machinery and strengthening of cell-cell adhesion structures. This barrier stabilizing effect is dependent on PI3K/Akt, NO/cGMP, and Rac1, which play a decisive role in insulin-mediated actin cytoskeleton rearrangement and stabilization of cell-cell adhesions. The proposed signal transduction pathways suggested by the data of the present study are illustrated in Figure 6E .
